Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Multiple myeloma arises from a type of white blood cell called a plasma cell. It develops when a normal plasma cell changes into a myeloma cell, which can multiply uncontrollably. Multiple myeloma ...

Cancer Nurs. 2008;31(3):239-249. The onset of fatigue typically occurs in the first or second cycle of treatment. [31] Most patients are able to continue therapy despite fatigue. Given the well ...

THICK blood smears (5–10 µl./cm. 2) can be grouped in the ABO blood group system by an absorptionelution technique which has been evolved in this Laboratory over the past two years.

Pap smears are one way to detect cervical cancer early ... or longer than normal vaginal discharge that is watery and has a strong odor or that contains blood pelvic pain or pain during sex “These ...

Results We determined the disturbance of systemic immunity caused by HCC and PDAC, and calculated a peripheral blood immune score (PBIScore) based on the constructed model. The PBIScore exhibited good ...

The malignant plasma cells replace normal blood cells, which can lead to anaemia, bone marrow failure and renal damage. Over the past two decades the paradigm of multiple myeloma therapy has ...

That's a great question, because quality of life is a very important concept that we need always to focus on, treating multiple myeloma ... for example, peripheral neuropathy that may affect ...

An unusual discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause. Pain during sex. Pain in the pelvic region. Pap smears are the ...

Some people with multiple myeloma ... This is called peripheral neuropathy. Myeloma proteins can damage the kidneys. Early on, this most likely won't cause any symptoms, but signs of kidney damage may ...

Background: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma liposomes have been linked to MM, ...

The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refractory multiple myeloma (RRMM) was a critical ...